Micron, Nike and More Earnings Coming Out This Week
24/7 Wall St. has put together a preview of a few major companies scheduled to report their quarterly results this coming week. The broad markets closed out last week with the Dow and S&P 500 holding near all-time highs. Also, the Nasdaq made a handy recovery over the course of the week. A strong earnings showing from these stocks could help the markets reach even higher highs.
We have included the consensus earnings estimates from Thomson Reuters, as well as the stock price and trading history.
Be advised that the earnings and revenue estimates may change ahead of the formal reports, and some companies could change earnings dates as well.
Monsanto Co.’s (NYSE: MON) latest quarterly earnings report is expected on Wednesday. The consensus analyst estimates are $1.77 in earnings per share (EPS) and $4.17 billion in revenue. Shares closed trading most recently at $117.02, in a 52-week range of $97.35 to $118.15. The consensus price target is $122.66.
Micron Technology Inc. (NASDAQ: MU) fiscal third-quarter results are scheduled for Thursday. The consensus earnings estimate is $1.50 per share, on $5.41 billion in revenue. The shares were last seen at $31.73. The consensus price target is $38.52, and the 52-week trading range is $11.50 to $32.93.
Nike Inc. (NYSE: NKE) is set to release its most recent quarterly results Thursday. The consensus forecast calls for $0.50 in EPS and $8.64 billion in revenue. Shares ended last week at $52.85. The consensus price target is $62.15, and the 52-week range is $49.01 to $60.33.
Rite Aid Corp. (NYSE: RAD) will report its most recent quarterly results on Thursday. The consensus estimates call for a net loss of $0.01 per share and $8.17 billion in revenue. Shares closed at $3.11 on Friday, in a 52-week range of $2.90 to $8.77. The consensus price target is $6.19.
Walgreens Boots Alliance Inc. (NASDAQ: WBA) fiscal third-quarter results are scheduled for Thursday as well. The consensus forecast is for $1.30 in EPS and $29.71 billion in revenue. Shares were last seen at $76.34. The 52-week range is $75.18 to $89.69, with a consensus price target of $93.41.